Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The related topics section no longer lists Melanoma and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2025-11-11T03:09:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:32:38.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic on melanoma, expanding core content to include genetic information about melanoma.
    Difference
    0.2%
    Check dated 2025-10-20T17:03:58.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    - Removed the MedlinePlus Genetics topic: Melanoma. No other content changes detected; overall impact is minor.
    Difference
    0.2%
    Check dated 2025-10-13T11:52:18.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T06:58:55.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:38:46.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.